One-year unplanned readmission after percutaneous coronary intervention in ST-elevation myocardial infarction: rates, causes, and predictors-a retrospective cohort study.

IF 2.8 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Frontiers in Cardiovascular Medicine Pub Date : 2025-09-16 eCollection Date: 2025-01-01 DOI:10.3389/fcvm.2025.1581371
O Alkhalaila, A Rahhal, M Altermanini, M S Abdelghani, M Shehadeh, K Shunnar, M B Habib, Y Hailan, M Barakat, M H Alkhateeb, M Al-Hijji, A R Arabi
{"title":"One-year unplanned readmission after percutaneous coronary intervention in ST-elevation myocardial infarction: rates, causes, and predictors-a retrospective cohort study.","authors":"O Alkhalaila, A Rahhal, M Altermanini, M S Abdelghani, M Shehadeh, K Shunnar, M B Habib, Y Hailan, M Barakat, M H Alkhateeb, M Al-Hijji, A R Arabi","doi":"10.3389/fcvm.2025.1581371","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Unplanned readmissions after percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) significantly impact healthcare systems. However, most of the existing literature focuses on short-term readmission rates and causes, with limited data on long-term readmissions. To date, no studies have evaluated the unplanned readmission post-PCI in STEMI patients within the Arab Gulf region. This study aimed to determine the rates, causes, and predictors of readmission post-PCI among STEMI patients over a one-year follow-up in Qatar, one of the Arab Gulf countries.</p><p><strong>Methods: </strong>We conducted a single-center retrospective cohort study at Hamad Medical Corporation in Qatar, involving 1,257 patients who underwent PCI during their index STEMI admission between January 1, 2016, and September 30, 2018. Patients were divided into two groups; (1) those who had one or more unplanned readmission within one year after PCI; (2) and those who did not have readmissions. The outcomes evaluated were the rates, causes, and predictors of all-cause and cardiac readmissions within one year post-PCI.</p><p><strong>Results: </strong>The mean age of the study population was 51 ± 10 years, and male gender presented 96%. The rate of all-cause readmission within one year post-PCI was 11.5%, with 8.2% due to cardiac reasons. Positive predictors of all-cause readmission included female gender (aOR = 4.14, 95% CI 2.10-8.18, <i>p</i> < 0.001), chronic kidney disease (aOR = 2.76, 95% CI 1.07-7.08, <i>p</i> = 0.035), more than one stent during PCI (aOR = 1.66, 95% CI 1.09-2.55, <i>p</i> = 0.019), and clinical heart failure during the index admission (aOR = 2.36, 95% CI 1.49-3.74, <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>This study highlights the need for targeted management strategies for high-risk populations to reduce readmission rates.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1581371"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12479441/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1581371","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Unplanned readmissions after percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) significantly impact healthcare systems. However, most of the existing literature focuses on short-term readmission rates and causes, with limited data on long-term readmissions. To date, no studies have evaluated the unplanned readmission post-PCI in STEMI patients within the Arab Gulf region. This study aimed to determine the rates, causes, and predictors of readmission post-PCI among STEMI patients over a one-year follow-up in Qatar, one of the Arab Gulf countries.

Methods: We conducted a single-center retrospective cohort study at Hamad Medical Corporation in Qatar, involving 1,257 patients who underwent PCI during their index STEMI admission between January 1, 2016, and September 30, 2018. Patients were divided into two groups; (1) those who had one or more unplanned readmission within one year after PCI; (2) and those who did not have readmissions. The outcomes evaluated were the rates, causes, and predictors of all-cause and cardiac readmissions within one year post-PCI.

Results: The mean age of the study population was 51 ± 10 years, and male gender presented 96%. The rate of all-cause readmission within one year post-PCI was 11.5%, with 8.2% due to cardiac reasons. Positive predictors of all-cause readmission included female gender (aOR = 4.14, 95% CI 2.10-8.18, p < 0.001), chronic kidney disease (aOR = 2.76, 95% CI 1.07-7.08, p = 0.035), more than one stent during PCI (aOR = 1.66, 95% CI 1.09-2.55, p = 0.019), and clinical heart failure during the index admission (aOR = 2.36, 95% CI 1.49-3.74, p < 0.001).

Conclusion: This study highlights the need for targeted management strategies for high-risk populations to reduce readmission rates.

st段抬高型心肌梗死经皮冠状动脉介入治疗后1年计划外再入院:发生率、原因和预测因素——一项回顾性队列研究
背景:st段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入治疗(PCI)后的意外再入院显著影响医疗保健系统。然而,现有文献大多关注短期再入院率和原因,长期再入院数据有限。迄今为止,没有研究评估阿拉伯海湾地区STEMI患者pci术后意外再入院。本研究旨在确定卡塔尔(阿拉伯海湾国家之一)STEMI患者pci术后再入院的发生率、原因和预测因素。方法:我们在卡塔尔哈马德医疗公司进行了一项单中心回顾性队列研究,纳入了2016年1月1日至2018年9月30日期间在STEMI入院期间接受PCI治疗的1257例患者。患者分为两组;(1) PCI术后一年内有一次或多次计划外再入院者;(二)没有再入境的。评估的结果是pci术后一年内全因再入院和心脏再入院的比率、原因和预测因素。结果:研究人群平均年龄为51±10岁,男性占96%。pci术后1年内全因再入院率为11.5%,其中心脏原因占8.2%。全因再入院的阳性预测因素包括女性(aOR = 4.14, 95% CI 2.10-8.18, p p = 0.035), PCI期间多于一个支架(aOR = 1.66, 95% CI 1.09-2.55, p = 0.019),以及指数入院时的临床心力衰竭(aOR = 2.36, 95% CI 1.49-3.74, p)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.80
自引率
11.10%
发文量
3529
审稿时长
14 weeks
期刊介绍: Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers? At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信